//
A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus
The Evolution of β-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5)
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
Clinical presentation, management, and 6-month outcomes in women with peripartum cardiomyopathy: an ESC EORP registry
Lateral Wall Dysfunction Signals Onset of Progressive Heart Failure in Left Bundle Branch Block
Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights From EMPEROR-Reduced
Natriuretic Peptide-Guided Heart Failure Therapy After the GUIDE-IT Study
Myeloid-Derived Growth Factor Protects Against Pressure Overload–Induced Heart Failure by Preserving Sarco/Endoplasmic Reticulum Ca2+-ATPase Expression in Cardiomyocytes